One Trader in family :- Upper middle class Two Traders in family:- Crazy money More than 3 Traders in family :- Wealth for generations to come! Join Telegram T.me/equitypocket

Psychology of trader

GOVERNMENT OF INDIA TO LAUNCH AN OFFER FOR SALE (OFS) TO DIVEST UP TO A 5% STAKE (8.77 CRORE SHARES); INCLUDES A BASE OFFER OF 2% (3.51 CRORE SHARES) AND AN OVERSUBSCRIPTION OPTION OF 3% (5.26 CRORE SHARES) OPENING JUNE 16, 2026

लगेगी आग तो आएँगे घर कई ज़द में,यहाँ पे सिर्फ़ हमारा मकान थोड़ी है Retail investor

17 Hospitals Future Management Aim (Next 3-5 Years) 🚀 🚀🚀 🎯 💥Highest Growth Ambition Potential 20–30% CAGR🚀🚀 🔹Krishna Institute of Medical Sciences 🔹Aster DM Healthcare 🔹Yatharth Hospital & Trauma Care Services 🔹Global Health 🔹Dr Agarwal's Healthcare - Very Aggressive Growth - Goal: Double beds, enter new cities, compound earnings 20% . 💥 Growth Quality Compounders (15–20% Earnings CAGR)🚀 🔹Max Healthcare Institute 🔹Apollo Hospitals Enterprise 🔹Narayana Health 🔹Rainbow Children's Medicare - Goal: Grow steadily while maintaining high returns on capital. 💥 Moderate Growth (10–15% Earnings CAGR)🚀🚀 🔹Fortis Healthcare 🔹Artemis Medicare Services 🔹Indraprastha Medical Corporation - Optimization Focus - Goal: Improve margins and utilization rather than pursue very aggressive expansion. 💥 Small-Cap / Special Situation 🚀 🔹Gujarat Kidney and Super Speciality 🔹Unihealth Hospitals 🔹Asarfi Hospital 🔹Hannah Joseph Hospital 🔹Park Medi World ........................................................................................................ 💥 For future growth potential (FY27–FY30), rank these hospital companies based on: 🔹 Bed addition pipeline 🔹 Occupancy ramp-up opportunity 🔹 ARPOB growth 🔹 Geographic expansion 🔹 Balance sheet strength 🔹 Management execution record 1. Yatharth Hospital & Trauma Care Services 🚀 Management Aim Build a dominant NCR healthcare platform. Expand through acquisitions and organic growth. Occupancy ramp-up from recently added capacity. Why: Smaller base allows faster earnings growth. Why high growth: NCR healthcare demand is booming. New facilities still ramping up. Occupancy has room to improve. Smaller base = faster compounding. Watch: Occupancy >70% ARPOB improvement Integration of acquisitions 2. Krishna Institute of Medical Sciences 🚀 Management Aim: Large multi-year bed addition program. Expand across South and East India. Maintain high ROCE while scaling. Key Trigger: New hospitals entering maturity phase. Why high growth: Strong presence in South India. Excellent capital allocation. Large expansion pipeline. Consistently high ROCE. 3. Aster DM Healthcare 🚀 Management Aim: Deploy large cash proceeds from GCC business monetization. Aggressive India expansion. Potential acquisitions. Significant bed capacity growth. Why it stands out: Has both capital and expansion opportunities. Can scale faster than most peers. Why high growth: Post-GCC restructuring. Large cash reserves. Aggressive India expansion. Potential acquisitions. 4. Rainbow Children's Medicare 🚀 Management Aim: Expand pediatric and maternity franchise nationally. Why high growth: Specialized pediatric niche. Strong brand among urban families. Expansion into new cities. Risk: Smaller addressable market than multispecialty hospitals. 5. Dr Agarwal's Healthcare 🚀 Management Aim: Consolidate fragmented eye-care industry. Continue acquisition-led growth. Expand clinic footprint rapidly. Why high growth: Asset-light eye-care model. High ROCE. Significant acquisition opportunity. 6. Global Health 🚀 Management Aim: Become a pan-India premium hospital brand. Significant capacity expansion in new markets. Why: Premium brand. New hospitals under development. Strong ARPOB growth. 7. Narayana Health 🚀 Management Aim: Expand capacity. Grow international operations. Improve profitability. Why: Improving international business. Strong cardiac franchise. Operating leverage. 8. Max Healthcare Institute 🚀 Management Aim: Significant bed additions. Selective acquisitions. Maintain industry-leading margins. Why: Best-in-class execution. High occupancy. Expansion through brownfield projects. Limitation: Already large scale. 9. Apollo Hospitals Enterprise 🚀 Management Aim: Continue expansion, but large base limits growth rate. Focus on ecosystem (hospital pharmacy digital). Why: India's strongest healthcare brand. Apollo 24/7. Pharmacy and diagnostics ecosystem. Limitation: Very large base. 10. Fortis Healthcare 🚀 Management Aim: Margin expansion. Operational optimization. Why: Stable operations. Margin improvement opportunities. Limitation: Slower expansion than peers. 11. Artemis Medicare Services 🚀 Why: NCR healthcare demand. Risk: Smaller scale and execution dependency. 12. Indraprastha Medical Corporation 🚀 Why: Mature flagship hospital. Limitation: Limited scalability. 💥 Speculative / Micro-Cap Growth Stories : 13. Gujarat Kidney and Super Speciality 14. Unihealth Hospitals 15. Asarfi Hospital 16. Hannah Joseph Hospital 17. Park Medi World Potential: Can grow very fast from a small base. Risks: Liquidity risk. Promoter dependence. Governance risk. Funding constraints. Expected growth: Unknown / High Risk .................................................................................................... - One-line takeaway For pure future growth guidance: Aster DM → KIMS → Yatharth → Medanta → Dr Agarwal's are currently the most aggressive expansion stories, while Max and Apollo remain the safest long-term compounders with slightly lower growth rates due to their larger size. - If you're looking specifically for "fastest future growth guidance" (not current quality or valuation), then focus on management's expansion plans, bed addition pipeline, and acquisition strategy. - If your objective is finding the next 3–5 year multibagger rather than the safest hospital stock, I would spend the most time studying KIMS, Yatharth, Aster DM, Medanta, and Rainbow, while using Apollo and Max as benchmark quality leaders. - Disclaimer: I am not a SEBI-registered research analyst. The information shared on this [website/channel/page] is strictly for educational and informational purposes only. #sharemarket #nifty #stocks #hospital #maxlife

🚨Following Israel’s Bombardment Of Beirut This Morning, Iran-US Negotiations Have Halted Iran will retaliate & Israel has raised its level of alert. This was expected & a predictable outcome. The U.S.-Israeli alliance is trying to force concessions out of the Iranians through this strategy, which is why Trump is claiming the Beirut strike shouldn’t have happened publicly, while privately green-lighting it. Source @MintPressNews

Vibhor Varshney, a SEBI RA (INH100005419) does this almost everyday. He tweets past performance of his clients, puts screenshots and deletes that tweet the next day and then puts up a new one. Mr. Varshney - since you are deleting these inducements, this implies you are aware that you are INTENTIONALLY violation SEBI RA Regulations. Still listing out for reference: SEBI prohibits an RA to: - Display Past performance (MC Clause 11.1(c)(xii)) - Show Misleading testimonials (MC Clause 11.1(c)(iii)) - Mislead by omission (MC Clause 11.1(c)(iv)) - Deliberately delete ads - 5-yr record rule (MC Clause 11.1(d)(v) RA Reg 25(2)) - Advisory and marketing shall be at arm’s length distance (RA reg 16(5)) There are more but you get the gist.

If any one looking for job in kanpur can contact

Breakout at weekly chart

Jsw energy retest complete Wait for green candle

🔻Find out the reasons for these stocks not moved up today, in fact dropped 2-4% 1. CEM Pro 2. Oil India 3. Nestle 4. ONGC 5. TECH M 6. One source pharma 7. Premier energies 8. Ipca lab 9. Cartrade tech 10. Lenskart Some are oil, some are IT, some are already rallied

Top 10 Indian core infrastructure & Express freight multipliers Only for educational purpose

ICICI bank strong candle . the reason i catch it right is human experience which no book and AI can teach you.

Top 10 Indian Capital Market Stocks Benefiting from the Investing & Trading Boom

🔥15 stocks that seen siginificant FII Buying ✅Bookmark & Follow @GingerInvest44 - Thread 🧵 1. Premier Energies FII Holding incresed by 1.24%

From my 8 years of experience in the markets, I stopped following and monitoring most traders after my first year. Why? Because almost everyone was busy showcasing only their winning trades while conveniently hiding their losses. The reality is simple: losses are a part of trading. They are inevitable. If someone claims they only win, you’re not watching a trader — you’re watching a clown trying to impress you and eventually separate you from your money. But the audience shares some responsibility too. Most people don’t want to see losses. They want a superhero who is always right, always winning, and never wrong. That’s exactly why fake gurus thrive. Be smart. Don’t follow the loudest person. Follow the transparent one. A trader who shows both wins and losses is far more trustworthy than someone selling a fantasy.

Micron, SanDisk and AMD , all crashing today. 🤯

Full form of ASAP WHAT ACTUALLY MEANS

Aloo le lo, kaanda le lo, reliance le lo, Sbi le lo 😜😆 GDP above expectation hai, hdfc le lo, icici le lo..

The limits for investment by NRIs and OCIs in equity instruments traded on the stock market without SEBI registration are being increased